CD8+ T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome

Journal: Nature Communications

Published: 2019-12-18

DOI: 10.1038/s41467-019-13593-5

Affiliations: 30

Authors: 36

Go to article
Institutions Share
University Hospital of Münster (UKM), WWU, Germany 0.29
Center for Brain Research (CBR), MUW, Austria 0.08
Faculty of Medicine and Health, USYD, Australia 0.06
Physiopathology Center of Toulouse-Purpan (CPTP), France 0.05
Hôpital Purpan, CHU-Toulouse, France 0.05
Brain and Mind Centre, USYD, Australia 0.04
University Hospital Nantes (CHU de Nantes), France 0.04
Department of Neurology, HHU, Germany 0.04
Department of Neurology at Medical Faculty Heidelberg, Uni Heidelberg, Germany 0.03
Institute of Neurology (CIN), MUW, Austria 0.03
Institute of Neuropathology, University of Göttingen, Germany 0.03
Institute of Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Germany 0.03
Institute of Neuropathology, WWU, Germany 0.03
Institute of Clinical Neuroimmunology, LMU, Germany 0.02
Cluster of Excellence - Cells-in-Motion (CiM), WWU, Germany 0.02
Biomedical Center München (BMC), LMU, Germany 0.02
Concord Repatriation General Hospital (CRG), USYD, Australia 0.02
Royal North Shore Hospital (RNSH), Australia 0.01
Center of Research in Transplantation and Immunology (CRTI), France 0.01
Alfried Krupp Hospital, Germany 0.01
Katholisches Klinikum Bochum (KKB), RUB, Germany 0.01
Cluster of Excellence - Munich Cluster for Systems Neurology (SyNergy), LMU, Germany 0.01
Royal Prince Alfred Hospital (RPAH), USYD, Australia 0.01
Berlin Institute of Health (BIH), Germany 0.01
Charité Cluster of Excellence - NeuroCure, Germany 0.01
Experimental and Clinical Research Center (ECRC), Germany 0.01
Toulouse University Hospital (CHU-Toulouse), France 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER